Bulk Pharmaceutical API Sources for FEMTRACE

Bulk Pharmaceutical API Sources for FEMTRACE

Vendor	Vendor Homepage	Vendor Sku	API Url
001Chemical		DY554278
BenchChem		B1242296
THE BioTek		bt-1575380
J&H Chemical Co.,ltd		JH297354
CymitQuimica		CQ_4245-41-4

Bulk Active Pharmaceutical Ingredient (API) Sources for FEMTRACE

Last updated: February 20, 2026

FEMTRACE (clomiphene citrate) is a selective estrogen receptor modulator (SERM) used primarily to treat infertility and ovulation disorders. The quality, purity, and regulatory compliance of its active pharmaceutical ingredient (API) are crucial for manufacturing. A thorough assessment of API sourcing options ensures supply security, cost-effectiveness, and regulatory adherence.

What Are the Key API Source Options for FEMTRACE?

FEMTRACE's API, clomiphene citrate, is sourced globally. Major suppliers include:

• India: Manufactures large quantities of APIs due to cost advantages; facilities often located in Hyderabad, Mumbai, and Gujarat.
• China: Provides significant API production capacity; some manufacturers focus on cost-efficient bulk supply.
• Europe: Contains several GMP-compliant API producers with higher quality standards.
• United States: Fewer manufacturers; often used for highly regulated markets requiring strict compliance.

Major API Manufacturers and Suppliers

Region	Notable API Producers	Manufacturing Capacity	Regulatory Status	Known for
India	Wockhardt, Hetero Drugs, Natco, Cipla	Large-scale	GMP, WHO-GMP	Cost-efficient, bulk production
China	Zhejiang Hisun, North China Pharmaceuticals	Large-scale	GMP	Competitive pricing, volume supply
Europe	Siegfried, Lonza, Candida Pharma	Moderate	GMP, EMA approved	High quality, specialized APIs
U.S.	Cambrex, Granules India	Moderate to high	FDA	Regulatory compliance, quality

Supplier Evaluation Factors

1. Regulatory Compliance: Must hold current GMP certificates, with a preference for FDA, EMA, or WHO approval.
2. Manufacturing Capacity: Ability to meet global demand, including contingency stocks.
3. Quality Assurance: Rigorous testing, batch consistency, and purity standards.
4. Pricing: Competitive costs suited for regional markets.
5. Lead Time: Reliable production schedules and shipment reliability.

Sourcing Strategies

• Single-Source Procurement: Reduces complexity but increases supply risk.
• Multiple Suppliers: Diversifies risk, enhances supply security.
• Regional Sourcing: Ensures faster delivery, improves regulatory oversight.

Regulatory & Quality Considerations

• Ensure API suppliers have valid certifications (GMP, ISO).
• Confirm batch-to-batch consistency with analytical data.
• Review supplier audits and third-party inspection reports.
• Verify regulatory status in target markets; some regions restrict imports of APIs without local GMP certs.

Supply Chain Risks

• Political and trade tensions affecting supply flow, particularly with China.
• Quality issues leading to batch rejections or recalls.
• Environmental or regulatory changes impacting manufacturing licenses.
• COVID-19 disruptions impacting global logistics.

Trends in API Sourcing

• Increasing preference for Asia-based suppliers due to volume and cost advantages.
• Rising demand for high-purity APIs meeting stricter regulatory standards in developed markets.
• Growing importance of Track-and-Trace systems to prevent counterfeit APIs.

Summary

Sourcing APIs for FEMTRACE involves balancing cost, quality, regulatory compliance, and supply reliability. India and China dominate global API production for clomiphene citrate, with European and U.S. suppliers focusing on higher standards. Multi-source strategies bolster supply security amid geopolitical and pandemic-related challenges.

---

Key Takeaways

• India and China are primary sources for FEMTRACE API, offering cost efficiency.
• European and U.S. manufacturers prioritize high regulatory standards.
• Supplier qualification includes GMP certification, quality assurance, and capacity.
• Multi-sourcing mitigates supply risks in volatile geopolitical conditions.
• Regulatory status influences supplier selection based on target markets.

---

FAQs

1. What certifications should I verify from API suppliers for FEMTRACE?
Suppliers should hold current GMP, ISO, and, if exporting to Europe or the U.S., EMA and FDA compliance certificates.

2. Can I source FEMTRACE API from multiple regions simultaneously?
Yes, diversifying sources from India, China, and Europe reduces supply risks but complicates quality management and regulatory oversight.

3. What are the risks in sourcing API from China?
Potential risks include regulatory standards variability, quality inconsistencies, and geopolitical tensions that could disrupt supply chain stability.

4. How can I ensure the quality of the API?
Perform qualification audits, review analytical testing results, and verify certifications. Engage third-party inspection services when needed.

5. What is the typical lead time for FEMTRACE API procurement?
Lead times vary from 4 to 12 weeks depending on supplier location, production schedule, and shipping logistics.

---

References

[1] World Health Organization. (2020). WHO guidelines on pharmaceutical quality assurance.
[2] European Medicines Agency. (2022). Good manufacturing practice guidelines.
[3] U.S. Food and Drug Administration. (2021). Guidance for industry: API manufacturing.
[4] Indian Pharmacopoeia Commission. (2022). Standards for APIs in India.
[5] Chinese Pharmacopoeia Commission. (2021). Standards for pharmaceutical raw materials.